Cohort study evaluates diagnostic accuracy of GAAD score for HCC in non-cirrhotic patients, suggesting its use in management decisions.
In this cohort of non-cirrhotic patients with focal liver lesions, the GAAD score was highly predictive of HCC and offered superior diagnostic accuracy over AFP and PIVKA-II alone. These findings support the use of the GAAD score to guide management decisions in these patients.
No takes yet. Share an insight, caveat, or question.
Moussa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: